A group of doctors claim the American Board of Psychiatry and Neurology monopolized the medical certification market.
AbbVie will commit less capital towards experimental medicines for psychiatric disease, CEO Robert Michael said at an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback